Literature DB >> 8599726

Neurotrophic factors in the therapy of peripheral neuropathy.

S C Apfel1, J A Kessler.   

Abstract

Neurotrophic factors are proteins that promote the survival and differentiation of specific populations of neurones. With the successful cloning and large-scale production of many different neurotrophic factors, it has become practical to consider their application in the treatment of neurological disease. Several groups of neurotrophic factors hold particular promise for the therapy of peripheral nervous system disease in the near future. These include the neurotrophin gene family, cytokines such as CNTF and the IGF family. Evidence is accumulating that an abnormal availability of some of these factors may contribute towards the pathophysiology of some types of neuropathy, most notably diabetic neuropathy. Pre-clinical studies in animal models have demonstrated the likely efficacy of factors such as NGF for small-fibre sensory neuropathy, BDNF, CNTF and IGF-I for motor neurone disease, and NT-3 for large-fibre neuropathy. Clinical trials of several growth factors are currently underway for the treatment of peripheral nerve disease, and other clinical trials are currently being planned.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8599726

Source DB:  PubMed          Journal:  Baillieres Clin Neurol        ISSN: 0961-0421


  10 in total

Review 1.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

2.  Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception.

Authors:  Kijung Sung; Luiz F Ferrari; Wanlin Yang; ChiHye Chung; Xiaobei Zhao; Yingli Gu; Suzhen Lin; Kai Zhang; Bianxiao Cui; Matthew L Pearn; Michael T Maloney; William C Mobley; Jon D Levine; Chengbiao Wu
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

Review 3.  Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment.

Authors:  Lakshya Motwani; Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman
Journal:  Cureus       Date:  2022-06-13

4.  Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.

Authors:  W F Goins; K A Lee; J D Cavalcoli; M E O'Malley; S T DeKosky; D J Fink; J C Glorioso
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 5.  Diabetic neuropathy.

Authors:  V Bansal; J Kalita; U K Misra
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

6.  Influence of Murraya koenigii on experimental model of diabetes and progression of neuropathic pain.

Authors:  S V Tembhurne; D M Sakarkar
Journal:  Res Pharm Sci       Date:  2010-01

Review 7.  Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions.

Authors:  Rozalyn L Rodwin; Namrah Z Siddiq; Barbara E Ehrlich; Maryam B Lustberg
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-14

8.  Effect of Fluoxetine on an Experimental Model of Diabetes-induced Neuropathic Pain Perception in the Rat.

Authors:  S V Tembhurne; D M Sakarkar
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

Review 9.  Nerve growth factor: from the early discoveries to the potential clinical use.

Authors:  Luigi Aloe; Maria Luisa Rocco; Patrizia Bianchi; Luigi Manni
Journal:  J Transl Med       Date:  2012-11-29       Impact factor: 5.531

Review 10.  Nerve Growth Factor: A Focus on Neuroscience and Therapy.

Authors:  Luigi Aloe; Maria Luisa Rocco; Bijorn Omar Balzamino; Alessandra Micera
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.